Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07476625Not ApplicableNot Yet Recruiting

Efficacy and Safety of Thalidomide for Pediatric PFAPA Syndrome

Role: collaborator

NCT07450872Recruiting

Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors

Role: collaborator

NCT05416918Completed

Clinical Value of Metagenomic Sequencing in Neonatal Sepsis

Role: collaborator

NCT05206799Unknown

The CMCPCTH Research in Chinese Children

Role: collaborator

NCT03953638Unknown

Application of Next Generation Sequencing Technique in Pediatric Bacterial Meningitis

Role: collaborator

All 5 trials loaded